Strategies and Pitfalls of CIP and Provisional Practice
The issues associated with U.S. provisional and CIP patent applications [...]
What’s Next for Design Patent Damages? DOJ Test on Trial
For all its eye-popping size, the $533 million award that [...]
An Update on the On-Sale Bar: Helsinn at the Supreme Court
The U.S. Supreme Court granted certiorari in Helsinn v. Teva in late [...]
Damages after Western Geco: Impact on Patent Litigation Strategy and Client Counseling
At the U.S. Supreme Court oral argument in Western Geco [...]
Willfulness after Halo
Enhanced damages for patent infringement no longer is a rarity [...]
Wilfullness after Halo
Enhanced damages for patent infringement no longer is a rarity [...]
Patent Eligbility in the Life Sciences: Exergen and Praxair- and USPTO Memos on Vanda and Berkheimer
Pity the life sciences patent prosecutor who tries to find [...]
Patent Eligibility in the Life Sciences: Exergen and Praxair- and USPTO Memos on Vanda and Berkheimer
Pity the life sciences patent prosecutor who tries to find [...]
A New PTAB Landscape: The Impact of SAS, Recent Federal Circuit Decisions, and the Proposed Change to the BRI Standard
This webinar features the Chief Judge of the PTAB in [...]
Protecting Brands under the New European Data Regulation
Owners of global brands will face a difficult challenge when [...]
